Biotech Values

[iwfal]

Hospital costs for the uninsured or underinsured at institutions such as MD Anderson may indeed be outrageous, but this has little to do with the problem addressed by the editorial: $100,000+ prices for cancer drugs that extend life very modestly.

Yes - and undoubtedly MD Anderson and these MDs make completely reasonable amounts of money in the same situation. Or not (e.g. oncologists are notorious for giving patients drugs that are VERY low probability of success - for instance an aquaintance of mine was just given Zelboraf for melanoma brain mets)?. So two docs from a flagrantly costly institution getting upset about drug prices is about as ironic as it gets.